Breadcrumbs Infectious Disease Epidemiology & Prevention Division Tuberculosis Prevention and Care Current: Health Care Professionals Health Care Professionals Reporting Forms Report of TuberculosisReport of Latent Tuberculosis InfectionTuberculosis Waiver Request Webinars May 2023 TB Update with Dr. Weaver & Dr. Allen - recording & slides (pdf)December 2023 TB Update with Dr. Crowder & Dr. Allen - slides (pdf) Guidance IDOH ResourcesIDOH TB Disease Treatment and Management Card (pdf) IDOH Latent TB Infection Screening and Treatment Card (pdf) TB Disease CDC Treatment for TB Disease webpageClinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children, ATS/IDSA/CDCClinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, ATS/ISSA/CDCInterim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022 Latent TB Infection (LTBI)Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020Additional ResourcesGlobal TB Institute at Rutgers LTBI Videos for Primary Care Providers
